ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Charlottes Web Holdings Inc (QX)

Charlottes Web Holdings Inc (QX) (CWBHF)

0.1069
-0.0031
(-2.82%)
Cerrado 30 Enero 3:00PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.1069
Postura de Compra
0.092
Postura de Venta
0.13
Volume Operado de la Acción
158,279
0.10 Rango del Día 0.11
0.074 Rango de 52 semanas 0.27
Precio Anterior
0.11
Precio de Apertura
0.10
Última hora de negociación
Volumen promedio (3 m)
255,543
Volumen financiero
US$ 17,076
Precio Promedio Ponderado
0.107885

CWBHF Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.002-1.836547291090.10890.120.11393450.11348021CS
40.017920.11235955060.0890.130.0861725900.11213954CS
12-0.0281-20.81481481480.1350.1470.0742555430.11288311CS
26-0.0671-38.56321839080.1740.1740.0742001490.12598191CS
52-0.0781-42.21621621620.1850.270.0742178560.15220999CS
156-0.7721-87.83845278730.8791.60.0742065850.39495008CS
260-7.4531-98.5859788367.567.80.0742974122.39893471CS

CWBHF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Charlottes Web (QX)?
El precio actual de las acciones de Charlottes Web (QX) es US$ 0.1069
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Charlottes Web (QX)?
Charlottes Web (QX) ha negociado en un rango de US$ 0.074 a US$ 0.27 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
RLLVFRelevium Technologies Inc (CE)
US$ 0.008
(799,900.00%)
8k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
318
CASGCanadian Aerospace Group International (CE)
US$ 0.001
(99,900.00%)
1,000
BLIBQBB Liquidating Inc (CE)
US$ 0.001
(99,900.00%)
204
NTBLQNotable Labs Ltd (CE)
US$ 0.0199
(19,800.00%)
21.97k
ISUNQiSun Inc (CE)
US$ 0.000001
(-99.90%)
200
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0.000001
(-99.50%)
453
JAMNJammin Java Corp (PK)
US$ 0.000001
(-99.00%)
156.25k
INTKIndustrial Nanotech Inc (PK)
US$ 0.000001
(-99.00%)
28.16k
SGMDSugarmade Inc (CE)
US$ 0.000001
(-99.00%)
35.78k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0002
(100.00%)
228.93M
GMPRGourmet Provisions International Corporation (PK)
US$ 0.000001
(-99.00%)
164.82M
HMBLHUMBL Inc (PK)
US$ 0.0007
(16.67%)
154.01M
THBDThird Bench Inc (PK)
US$ 0.0001
(-33.33%)
133.1M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0028
(-6.67%)
110.11M

CWBHF Discussion

Ver más
Fangster Fangster 7 horas hace
Gee, who could the thumbs downer be 🤣.

I'd be watching AJNA very close.  The JV through Deforia with CW will be opening a few eyes.   Good things going on there! 
👍️0
DarthYoda DarthYoda 11 horas hace
DeFloria-"A Novel Botanical Drug for Autism":
IND Filing Q1 2025 & Phase 2 Entrance Q2 2025
https://foundersuite.com/public_pitch_decks/cc7fb59a-333b-4d4d-9f8f-e0d3c732c2a0
https://defloria.bio/
👍 1 👎️ 1
DarthYoda DarthYoda 1 día hace
"Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug":
Jan 24, 2025
As a botanical drug candidate, the road to approval is less linear. “A lot of people don't even realize that the FDA has a different regulatory regime for botanical drugs,” Stanley says. “And only four botanical drugs have been approved. And none of those are oral system. Three of them are topical and one of them coats the GI tract, so they're not absorbed by the body.”
They have the right team for the job. Dr. Orrin Devinski, who was the lead principal investigator for Epidiolex, is Ajna's chief medical officer and oversees the clinical trial design. Epidiolex is the only non-synthetic cannabis drug to get through the FDA approval process. Devinski is also director at the Comprehensive Epilepsy Center at NYU Langone.
https://www.forbes.com/sites/benjaminadams/2025/01/24/charlottes-web-founder-aims-for-fda-approval-of-autism-spectrum-disorder-drug/
"What is a Botanical Drug?":
https://www.fda.gov/about-fda/cder-offices-and-divisions/what-botanical-drug
"Botanical Drug Development: Guidance for Industry":
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/botanical-drug-development-guidance-industry
👍 1 👎️ 1 💯 1
DarthYoda DarthYoda 2 días hace
I know my metals talk has nothing to do with the company's current business plan, but it does look like I was onto something...Because of the battery and electric vehicle boom Nickel is actually the metal for which phytomining is being researched the most...The new research below is exactly what should be done with hemp. It may turn out to be the best candidate for the job...
"US scientists engineer plant to harvest precious minerals, improve soil, create biofuel":
1/28/2025
“Our idea” Dhankher said as per the UMass Amherst release, “is to determine which genes and proteins are responsible for Alyssum’s nickel hyperaccumulation, then re-engineer Camelina so that it, too, can hyperaccumulate nickel. We also want to determine which soil amendments will optimize the engineered Camelina’s ability to pull even more nickel from the soil.”
https://www.msn.com/en-us/science/environmental-science/us-scientists-engineer-plant-to-harvest-precious-minerals-improve-soil-create-biofuel/ar-AA1y081c
"The Feds Are Trying to Get Plants to Mine Metal Through Their Roots":
Mar 21, 2024
Some species can absorb extreme amounts of nickel from soils. Such “phytomining” could help provide batteries essential for the renewable revolution.
Of the 350,000 known plant species, just 750 are “hyperaccumulators” that readily absorb sky-high amounts of metals and incorporate them into their tissues.
https://www.wired.com/story/the-feds-are-trying-to-get-plants-to-mine-metal-through-their-roots/
With that all being said, if hemp is now also being looked at to pull PFAS(forever chemicals) out of the ground, you gotta wonder if CBD can protect against the effects of PFAS, similarly to how it can protect from heavy metals toxicity...
"Viability of Hemp as a PFAS Remediation Tool Moves Forward, as Contamination Spreads":
January 23, 2025
“Starting in 2025, the Mi’kmaq Nation, [Upland Grassroots], [University of Virginia], the Connecticut Agricultural Experiment Station and Central Aroostook Soil and Water Conservation District will use a four-year, $1.6 million EPA grant to continue hemp planting at [the former] Loring [Air Force Base] and testing potential ways to extract PFAS [per- and polyfluoroalkyl substances] from harvested hemp.”
https://beyondpesticides.org/dailynewsblog/2025/01/viability-of-hemp-as-a-pfas-remediation-tool-moves-forward-as-contamination-spreads/
"Minnesota Just Became the First State to Target Plastic Chemicals in Food":
January 22, 2025
On January 16, Gustafson introduced bill SF 188, which aims to pressure food manufacturers to reduce their use and levels of phthalate chemicals — plasticizers used to make plastics more flexible and durable — in their products.
https://www.foodandwine.com/minnesota-bill-sf188-phthalate-testing-packaged-foods-8777895
👍️0
DarthYoda DarthYoda 3 días hace
Hey good to see you Fangster. I agree about the food. There are a lot of issues in this sector. All are government dependent unfortunately. There is no free market. There is no sense in how they approach food, drugs, dietary supplements, even without cannabis. So much needs to be fixed. However, next week on Feb 5th there will be a banking hearing so maybe that is a start...
https://www.marijuanamoment.net/marijuana-businesses-tell-gop-senate-committee-about-struggles-accessing-financial-services-ahead-of-debanking-hearing/
Oh, and FWIW, hemp plants CAN pull soluble precious metals like Gold and Palladium out of the ground. It's called phytomining, but there hasn't been much effort to research it thoroughly to see how well it could work after things like selective breeding for enhanced metals absorption...
"Phytoextraction of palladium and gold from Broken Hill gossan" :
2015
A second trial used Cannabis sativa (Hemp) due to recorded metal tolerance of this species. Pots were re-seeded with C. sativa. Hemp germinated and grew well relative to B. juncea. Potassium cyanide solution (50 mL of 8 g L-1) was applied to each pot at the point of maximum biomass to induce the solubility of precious metals and therefore to induce hyperaccumulation. Significant metal concentration values after KCN treatment were as follows: Copper (6,726 µg g-1) > nickel (184 µg g-1) > palladium (62 µg g-1) > gold (9 µg g-1). Following established criteria values, copper, palladium, and gold hyperaccumulation was observed. The mean metal concentrations of copper, nickel, and palladium from Hemp grown in soil B were greater compared to Hemp grown in soil A and control plants (p < 0.05). However, gold concentration between Hemp A and Hemp B was not different significantly (p > 0.05).
https://mro.massey.ac.nz/items/58b8f1c0-2e1b-4180-b374-90125a6b8446
"Phytomining: Can plants really grow gold?":
May 1, 2013
https://www.mgsrefining.com/blog/phytomining-can-plants-really-grow-gold/
"Phytomining of noble metals – A review":
6 August 2021
https://www.sciencedirect.com/science/article/pii/S0045653521022773
👍️0
Fangster Fangster 5 días hace
DY, very interesting posts.  It's long past the point for the FDA and whatever other alphabet agency come clean and address the real health hazards of fast and processed foods.  

It really should NOT take scientific studies to confirm these issues.  The ballooning health care crisis overwhelming society tells the story.  Just look at individuals over 30 that live chemically infused foods vs. those that don't.  In most cases, it clear who's eating what.  

 
👍️0
DarthYoda DarthYoda 5 días hace
"100% of Fast Food Samples Tested Positive for Heavy Metals, Lead, and Cadmium":
October 12, 2023
Summary
-100% of the fast food samples tested contained alarming levels of cadmium.The levels of cadmium were between 74%-1158% higher than what the EPA allows in drinking water.
-Cadmium is highly carcinogenic and can cause toxic reactions even at low levels.
-In-and-Out french fries had 1,158% higher levels of cadmium than what the EPA allows in drinking water.
-Jack-in-the-Box french fries had 970% higher levels of cadmium than what the EPA allows in drinking water.
-100% of the 42 fast food samples tested had trace amounts or higher of lead.
-Even low levels of lead in blood have been shown to negatively affect a child’s intelligence, ability to pay attention, and academic achievement.
-A Sonic Drive-in cheeseburger had the highest amount of lead, 912% higher than what the EPA allows in drinking water.
-Arsenic was also detected in 17% of the fast food samples.
-The highest level of arsenic was found in Panda Express’s orange chicken and white rice at 362% higher than EPA levels allowed in drinking water.
Cadmium
The highest level of cadmium was found in fast food french fries. This is presumably because potatoes are grown in the ground and absorb more heavy metals in the growth process. In-and-Out had 1,158% higher levels than what the EPA allows in drinking water, and Jack-in-the-Box had cadmium levels 970% higher than what the EPA allows in drinking water. According to a March 2023 paper by Wang et al. “Cadmium (Cd) is a highly carcinogenic metal, which can cause toxic reactions even at low concentrations. Long-term ingestion of high-dose Cd can cause serious health problems (Ankit et al., 2021).
The paper further explains how cadmium may be polluting food. “Application of sewage sludge, farmyard manure, or some commercial fertilizers may also increase Cd levels in the soil (Bigalke et al., 2017, Kubier et al.,)” The paper also points to reasons “such as dumping of domestic or industrial wastewater (Rao & Kashifuddin, 2016), and misuse of phosphate fertilizer.”
https://www.momsacrossamerica.com/fast_food_heavy_metals
You would think our "food" would at least have to be as clean as our cannabis, but no.
👍 1 💯 1
DarthYoda DarthYoda 6 días hace
This preprint research paper shows hemp/CBD protects against Lead toxicity and another paper shows it even protects against Copper toxicity too. Maybe it's ability to modulate a wide variety of metals will become more important in the future. Maybe Hemp can pull Gold, Silver, Platinum, Palladium out of the ground...
"Evaluation of the protective effect of cannabidiol in lead toxicity in mice":
12 Feb, 2024
Conclusion
This study showed that CBD has a protective effect against Pb toxicity. This finding indicates that CBD could be used as a food additive or supportive treatment for alleviating the toxic effects of Pb at risked population groups.
https://www.researchsquare.com/article/rs-3936708/v1

"Therapeutic Role of Hemp (Cannabis sativa) Against Copper-Induced Toxicity in Labeo rohita and Cirrhinus mrigala":
03 April 2023
"In conclusion, hemp seed supplementation showed significant (P < 0.05) improved results against copper toxicity. Thus, it could be recommended as an animal feed ingredient for its therapeutic role."
https://link.springer.com/article/10.1007/s12011-023-03650-y
👍️0
DarthYoda DarthYoda 1 semana hace
Interesting circle of life...heavy metal content(Cadmium) in soil modulates cannabinoid content in hemp and then the hemp's cannabinoid content (CBD specifically) modulates heavy metals, and their toxicity, in humans...
"Study: CBD Protects Against Some of the Toxic Effects of Cadmium":
Jan 21,2025
https://themarijuanaherald.com/2025/01/study-cbd-protects-against-some-of-the-toxic-effects-of-cadmium/
Here is the actual paper..."Investigation of Cannabidiol's Protective Effects on Cadmium-Induced Toxicity in Mice":
2025 Feb
https://pubmed.ncbi.nlm.nih.gov/39832793/
"Cadmium in Food and Foodwares":
https://www.fda.gov/food/environmental-contaminants-food/cadmium-food-and-foodwares
"Dietary exposure to cadmium from six common foods in the United States":
June 2, 2023
https://www.sciencedirect.com/science/article/pii/S0278691523002752
"Cannabidiol Protects (human)Dopaminergic Neuronal Cells from Cadmium":
2019 Nov
https://pmc.ncbi.nlm.nih.gov/articles/PMC6888634/
"Protective effect of cannabidiol against cadmium hepatotoxicity in rats":
2013 Oct
https://pubmed.ncbi.nlm.nih.gov/23993482/
"Identification of MYB genes reveals their potential functions in cadmium stress response and the regulation of cannabinoid biosynthesis in hemp":
8 March 2022
"Industrial hemp (Cannabis sativa L.) is an important fiber crop used to remediate soils contaminated with heavy metals. Studies have shown that exogenous Cd(Cadmium) stress can affect the production of secondary metabolites in industrial hemp plants."
https://www.sciencedirect.com/science/article/abs/pii/S0926669022000905
👍️0
Thomas@yahoo Thomas@yahoo 2 meses hace
How about CBD analysts John Smith/ (Pinocchio) also recommending TCNNF and Ayrwf besides cwbhf 😆🤣
💀 2 ☠️ 2
Wolf-man jack Wolf-man jack 2 meses hace
WQLF SAYS CWBHF Sucks 10 Pennies and falling YQU DO Understand YQU Understand. Have Mercy WQLF Ahooooooo

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=17552012
☝️
👍️ 2 💥 1 ☠️ 1
Thomas@yahoo Thomas@yahoo 2 meses hace
EXTRACT LABS X 16 ✅✅✅✅✅✅✅✅✅✅✅✅✅✅✅✅
https://data.food.gov.uk/cbd-products/products-list?page=2&row-limit=10&search=Extract+Labs

https://ir.cvsciences.com/press-releases/detail/231/cv-sciences-inc-enters-into-definitive-agreement-to
👍️ 2 💥 2
Thomas@yahoo Thomas@yahoo 2 meses hace
EXTRACT LABS ✅
https://data.food.gov.uk/cbd-products/products-list?page=2&row-limit=10&search=Extract+Labs

https://ir.cvsciences.com/press-releases/detail/231/cv-sciences-inc-enters-into-definitive-agreement-to
👍️ 2 💥 2
Wolf-man jack Wolf-man jack 2 meses hace
WQLF SAYS;

https://data.food.gov.uk/cbd-products/products-list?search=Cbdmd
👍️ 2 💥 1
Wolf-man jack Wolf-man jack 2 meses hace
WQLF SAYS: ALL 34 SKU’s Removed. Oh My My Have Mercy WQLF Ahooooooo

https://data.food.gov.uk/cbd-products/products-list?page=1&row-limit=10&search=Charlotte+s+Web

Wolfman Jack Says: Oh My My You Understand. Ahooooooo



https://data.food.gov.uk/cbd-products/products-list?search=Cbdmd
👍️ 1 🤣 1
ap17 ap17 2 meses hace
Interesting.
💀 1 ☠️ 1
Wolf-man jack Wolf-man jack 2 meses hace
WQLF SAYS: It just dawned on me that JD mentioned Cannabis in the call. I believe the company is going to merge with or acquire a Cannabis
Company. Your thoughts?

“We will continue to participate in the contraction and consolidation of both the CANNABIS and HEMP industries and will evaluate both inbound and outbound M&A opportunities that have strategic value and help scale our company profitably.”
👍️ 1 🤔 1
Wolf-man jack Wolf-man jack 3 meses hace
https://www.sec.gov/ix?doc=/Archives/edgar/data/1750155/000175015524000071/cweb-20240930.htm
💀 1 ☠️ 1
Wolf-man jack Wolf-man jack 4 meses hace
WQLF SAYS; 🍄 🍄‍🟫

https://www.charlottesweb.com/blogs/learn/functional-mushroom-benefits
👎️ 1
Wolf-man jack Wolf-man jack 4 meses hace
WQLF SAYS;

“Charlotte's Web" or the "Company"), the market laggard in cannabidiol (CBD) hemp extract wellness products, stands in firm opposition to the new regulations in California that restrict the sale of many ingestible full-spectrum hemp CBD products that meet federal requirements.”

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175135284
👍️ 1 ☠️ 1
Wolf-man jack Wolf-man jack 4 meses hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175135284
👍️ 1 ☠️ 1
ap17 ap17 4 meses hace
Nice, thanks
☠️ 1
DarthYoda DarthYoda 4 meses hace
"Fourth Circuit Court Rules Hemp-Derived Products Legal Nationwide, Contradicting DEA":
Sep19, 2024
The Fourth Circuit Court of Appeals has ruled that all hemp-derived products, including those created through chemical synthesis, are legal under federal law.

This ruling aligns with a 2022 decision from the Ninth Circuit but goes against more recent guidance from the DEA. In a letter from February 2023, the DEA stated that the 2018 Farm Bill was not intended to legalize synthetic cannabinoids, such as THC-O, even if their THC content is below the legal limit.

Despite acknowledging the disagreement, the Fourth Circuit sided with the Ninth Circuit’s interpretation, which held that the Farm Bill’s definition of hemp includes all cannabis plant derivatives as long as they contain less than 0.3 percent delta-9 THC. The court stated that this interpretation is clear and that they did not need to defer to the DEA’s position.

“The Ninth Circuit held that it didn’t need to consider the DEA’s position on synthetically derived substances because the definition of ‘hemp’ under the 2018 Farm Act was unambiguous in its application to all products derived from the cannabis plant, ‘so long as they do not cross the 0.3 percent delta-9 THC threshold,’” states the court. “Between the DEA’s February 2023 letter and [the Ninth Circuit decision], we think the Ninth Circuit’s interpretation of the 2018 Farm Act is the better of the two. And we’re free to make that determination ourselves, despite a contrary interpretation from the DEA, because we agree with the Ninth Circuit that § 1639o is unambiguous.”

The case arose from a dispute over whether an employer could fire an employee for using hemp products. The court ultimately upheld the firing because the employee failed to prove the products used were compliant with the THC limits outlined in the 2018 Farm Bill.
https://themarijuanaherald.com/2024/09/fourth-circuit-court-rules-hemp-derived-products-legal-nationwide-contradicting-dea/

"New Study Reveals CBD’s Surprising Ability To Combat Deadly Mosquitoes":
September 20, 2024
CBD results in 100% mortality of pesticide-resistant mosquito larvae.

New research in the effort to address global insecticide resistance has found that CBD, commonly used to manage various health conditions, is also highly effective in eliminating mosquito larvae.

The study, published in the journal Insects, found that hemp leaf extract – which contains the active ingredient cannabidiol, or CBD – kills mosquito larvae from two different strains of the yellow fever mosquito within 48 hours, one that was resistant to typical insecticides and another that was not.

“Mosquitoes are one of the deadliest animals in the world, mainly because as adults they serve as vectors of disease,” said Erick Martinez Rodriguez, lead author of the study and a graduate student in entomology at The Ohio State University. “It’s very important to be able to control these pests at an early stage, when they are at the most vulnerable.”

Unlike adult mosquitoes that can fly across great distances and transmit disease by biting, mosquito larvae are aquatic organisms often found in standing water. Conventional synthetic insecticides are critical chemical tools for killing mosquito larvae populations, but their rampant overuse has led to both insecticide resistance and other detrimental effects on the environment.

Challenges of Conventional Insecticides
Inspired by previous Ohio State research that discovered that the bark properties of a plant native to Madagascar worked as a natural mosquito insecticide and repellent, Martinez Rodriguez sought to determine if hemp could act as a viable and safe alternative to current biopesticides.

The hemp plant is related to marijuana, but does not contain its levels of the ingredient that makes people feel “high.” CBD from hemp is used in a variety of products from gummies and oils to treat anxiety, pain, insomnia, and other conditions.

To test hemp’s toxic effects against mosquito larvae, the team took air-dried hemp leaves, pulverized them into a fine powder, and soaked the material in methanol for a few weeks to reach the desired CBD concentrations.

The methanol was later removed from the solution to make it easier to chemically analyze, resulting in an extract that was eventually given to the larvae with their food.

Depending on the concentration of hemp extract used, the team discovered that the hemp leaf was potent enough to be equally toxic to both strains of mosquito larvae. What was surprising, though, said Martinez Rodriguez, was the small amount needed to be so deadly.

“If you compare the amount of hemp extract needed to kill 50% of the population to other synthetic conventional insecticides, it is on the high side, but when you compare it side-by-side to other natural extracts we have tested in our lab, only a relatively low amount is required to produce high mortality values in larvae,” said Martinez Rodriguez. While CBD eventually led to 100% mortality for the larvae, different concentrations of the hemp extract caused different mortality rates in the hours leading up to that time.

Hemp’s Advantages and Future Research Directions
The mosquito larvae were considered dead if no movement was recorded after scientists gently touched their abdomen with a needle or pipette tip. Although it’s still unclear how the extract affects them biologically, the team’s findings showed that CBD was the primary active ingredient in the extract and that it can successfully bypass the larvae’s metabolic resistance to other insecticides, which aligns with past work that found CBD has notable growth-inhibiting properties against other insects.

Since hemp is also a more sustainable crop than many other plant alternatives, insecticide products that use it could potentially be produced relatively cheaply, said Martinez Rodriguez.

While this discovery bodes well for developing future natural-based mosquito control products, said Peter Piermarini, co-author of the study and a professor of entomology at Ohio State, further research would have to be done to investigate how safe hemp and CBD would be for non-target organisms, like honey bees or other pollinating insects that scientists don’t want to kill or disrupt by introducing potentially harmful additives to the environment.

“CBD is a compound that appears to be safe for people and our companion animals to ingest,” said Piermarini. “It’ll be interesting to learn more about how CBD interacts with various proteins in mammals and insects to understand why it’s safe for people but not insects.”

Reference: “Larvicidal Activity of Hemp Extracts and Cannabidiol against the Yellow Fever Mosquito Aedes aegypti” by Erick J. Martínez Rodríguez, P. Larry Phelan, Luis Canas, Nuris Acosta, Harinantenaina L. Rakotondraibe and Peter M. Piermarini, 9 July 2024, Insects.
DOI: 10.3390/insects15070517

This work was supported by the Infectious Diseases Institute and the College of Food, Agricultural, and Environmental Sciences at Ohio State. Other Ohio State co-authors include Larry Phelan, Luis Canas, Nuris Acosta and Harinantenaina L. Rakotondraibe.
https://scitechdaily.com/new-study-reveals-cbds-surprising-ability-to-combat-deadly-mosquitoes/
👍️ 2 👎️ 1 ☠️ 1
ap17 ap17 5 meses hace
What's going on here, besides the share price approaching CV's.
👍️ 1 ☠️ 1
Wolf-man jack Wolf-man jack 6 meses hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174604606

https://finance.yahoo.com/news/organigram-reports-third-quarter-fiscal-103000048.html
👍️ 2 ☠️ 1
ap17 ap17 6 meses hace
ouch!!
👍️ 2 ☠️ 2
Thomas@yahoo Thomas@yahoo 6 meses hace
More GREAT NEWS FOR CV SCIENCES
https://www.greenmarketreport.com/california-cannabis-business-orgs-raise-red-flags-over-proposed-hemp-supply-chain-integration/
👍️ 2 💥 2
Wolf-man jack Wolf-man jack 6 meses hace
“ Charlotte's Web Holdings, Inc. (TSE:CWEB) just released its latest quarterly report and things are not looking great. It definitely looks like a negative result overall with revenues falling 14% short of analyst estimates at US$12m. Statutory losses were US$0.07 per share, 40% bigger than what the analysts expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Charlotte's Web Holdings after the latest results.

Following the recent earnings report, the consensus from three analysts covering Charlotte's Web Holdings is for revenues of US$50.8m in 2024. This implies a measurable 6.9% decline in revenue compared to the last 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 33% to US$0.19. Before this earnings announcement, the analysts had been modelling revenues of US$57.5m and losses of US$0.22 per share in 2024. We can see there's definitely been a change in sentiment in this update, with the analysts administering a meaningful downgrade to next year's revenue estimates, while at the same time reducing their loss estimates.

The consensus price target fell 14% to CA$0.65, with the dip in revenue estimates clearly souring sentiment, despite the forecast reduction in losses.”


https://finance.yahoo.com/news/earnings-release-heres-why-analysts-122818344.html
👍️ 2 🫣 1 ☠️ 1
MaxwellE MaxwellE 6 meses hace
$.15 per share, that's about $.10 per share more than it's worth...M
👍️ 2 🗯️ 1 ☠️ 1
GE_Jim GE_Jim 6 meses hace
Well thats interesting. we'll see how it plays
👎️ 1
DarthYoda DarthYoda 6 meses hace
"Citing failures to protect public health, lawmaker looks to remove FDA's food authority":
August 2nd 2024
Rep. Rosa DeLauro (D-CT), who's been in Congress for more than three decades, has had enough.
She's introduced legislation to remove the FDA's food authority and start fresh with a new agency: The Federal Food Administration.
https://wjla.com/resources/pdf/1425c052-a30c-4578-90ea-6744f83ac635-TAM24855.pdf
The agency sent us the below statement:
"As you may be aware, in May the FDA reached a significant milestone with approval of its reorganization involving the creation of a unified Human Foods Program (HFP), adoption of a new model for its field operations and other significant modernization efforts. The reorganization implementation is currently targeted for Oct. 1, 2024, notably enhancing the agency’s ability to oversee and protect the human food supply and other products the FDA regulates. The reorganization will enable the FDA to be more efficient, nimble and prepared for the ever-changing and complex industries we regulate, new food and medical product technologies, as well as the impacts of globalization, climate change and other factors that require the agency to quickly adapt.

Additional information can be found here:
https://www.fda.gov/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and
https://wjla.com/news/spotlight-on-america/toxic-baby-food-fda-citing-failures-protect-public-health-formula-bacteria-heavy-metals-tainted-applesauce-rosa-delauro-connecticut-test-contaminants-safe-products
👍️0
DarthYoda DarthYoda 6 meses hace
You got it. Here's something from the Gov side...
"Congress Advances Cannabis and Hemp Proposals":
July 29, 2024
https://www.jdsupra.com/legalnews/congress-advances-cannabis-and-hemp-5541083/
👎️ 1
GE_Jim GE_Jim 6 meses hace
Thanks for the post. I have taken a step back, need to see clarity from the gov. side. Just going to enjoy summer till then.
😿 1
Wolf-man jack Wolf-man jack 6 meses hace
https://finance.yahoo.com/news/charlottes-2024-second-quarter-earnings-123700472.html
🚭️ 1 ☠️ 1 ⛔️ 1
DarthYoda DarthYoda 6 meses hace
I found a recently published research paper that was funded by Charlotte's Web, and I threw in a couple more papers below it as well. The one funded by Charlotte's Web is focused on a new cannabinoid called Cannabielsoin or CBE, (there is S-CBE and R-CBE, this paper focused on S-CBE), which is an oxidation product of CBD. You guys know I love seeing stuff like this...Enjoy!

"Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist":
Published: 12 July 2024
Funding
Funding for this study was provided by Charlotte’s Web.
https://www.mdpi.com/2227-9059/12/7/1551

"Cannabidiol ameliorates lipopolysaccharide-induced cardiovascular toxicity by its antioxidant and anti-inflammatory activity via regulating IL-6, Hif1a, STAT3, eNOS pathway":
18 July 2024
Results
Histopathological analysis of the LPS group showed moderate hyperemia, hemorrhages, edema, inflammation, and myocardial cell damage. There was a slight to moderate increase in Cox-1, G-CSF, and IL-3 immunoexpressions, along with enhanced expressions of IL-6, Hif1a, and STAT3 genes, and decreased expressions of eNOS genes. Additionally, there were increased levels of TOS and decreased TAS levels observed biochemically. CBD treatment effectively reversed and improved all of these observed changes.

Conclusions
CBD protects the heart and aorta against systemic inflammation through its antioxidant and anti-inflammatory activity via regulating IL-6, Hif1a, STAT3, and eNOS intracellular pathways.
https://link.springer.com/article/10.1007/s11033-024-09772-3

"Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States":
19 July 2024
Results: Ninety-seven products were purchased (35 in-store, 62 online). Of the 71 products with a specific total CBD amount on the label, 35 (49%) were underlabeled (>10% more CBD than advertised), 27 (38%) were overlabeled (>10% less CBD than advertised), and 9 (12.7%) were accurately labeled (within ±10% of labeled CBD). The median (range) percentage deviations were -53% (-100%–76%) for haircare products, +18% (-100%-1076%) for cosmetics, and -1% (-100%-4468%) for food/drinks. CBD label accuracy did not differ significantly between products with external testing claims versus those without (t40 = 0.23, p = 0.82). Overall, 24% of the 97 (total) products made a cosmetic or beauty claim (e.g., “skin looks more youthful”), 40% made a therapeutic claim (e.g., “pain relief”), and 86% made a health halo effect claim (e.g., “paraben-free,” “dye-free,” etc.). Most products (63%) did not include a disclaimer that claims had not been evaluated by the FDA.
Conclusions: Most of the products included in this sample were inaccurately labeled for CBD content, including those claiming to have been tested by third party laboratories. A notable finding was that 10 products did not contain any CBD. Many products made therapeutic claims or used marketing tactics to seemingly convey they were safe/healthy, but only about one-third included disclaimers that these statements had not been evaluated by the FDA. These findings highlight the need for proper regulatory oversight of cannabinoid-containing products to ensure quality assurance and deter misleading or unfounded health claims in product marketing.
https://www.liebertpub.com/doi/abs/10.1089/can.2024.0039
☠️ 1
DarthYoda DarthYoda 7 meses hace
"Case Report: Cannabis Oil Treats Common Skin Disease in Dog":
JUL 11, 2024
Veterinary students and scientists in Brazil used cannabis oil to successfully treat a dog with a common skin disease that did not respond to previous treatment. The corresponding study was published in Frontiers in Veterinary Science.

Discoid lupus erythematosus (DLE) is a common autoimmune disease that typically affects the skin on the nose and ears of dogs. It is characterized by inflammation, loss of hair pigment, and redness, which can lead to crusting and ulceration. The condition's underlying cause remains unknown; however, it is thought to arise from a mix of genetics, infections, hormones, and sun exposure. Current treatments include corticosteroids to reduce inflammation; however, these carry a risk of unwanted side effects.

Previous research suggests that cannabinoids cannabidiol (CBD) and tetrahydrocnnabidiol (THC) reduce inflammation in both dogs and humans without any detrimental side effects.

In the current case report, a two-year-old female mixed-breed dog with DLE was not responding to corticosteroids and other medications. The researchers thus decided to treat the dog with cannabis oil.

After some experimentation, they found that cannabis oil containing CBD and THC on a ratio of 3:1 worked best. To begin, the dog was given a single drop orally once daily for three days to test for negative reactions. The treatment continued after no negative reactions were reported, and the dosage was slowly adjusted until the minimum effective dose was found. After several weeks, some signs of DLE started to disappear, and after a year, all symptoms were relieved.

"After 1year, the dog remains clinically stable on a low dose of full-spectrum CBD-rich oil. No evidence of DLE recurrence was observed," wrote the researchers in their paper.

“This case suggests that cannabinoid therapy (CT) may be a viable alternative or complementary therapy for DLE in dogs, particularly for those experiencing adverse effects from conventional treatments. Further research is warranted to confirm the efficacy and safety of CT for DLE management in dogs,” continued the researchers.
https://www.labroots.com/trending/cannabis-sciences/27420/report-cannabis-oil-treats-common-skin-disease-dog-2
Here is the actual paper...
"Case report: Cannabinoid therapy for discoid lupus erythematosus in a dog":
https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1309167/full
👍️ 1
ap17 ap17 7 meses hace
NICE!! the agencies are a cancer to the world.
👍️ 1
DarthYoda DarthYoda 7 meses hace
Here's an article that gets into more specifics...
"How the Supreme Court Overturning a Case Against Chevron Oil Threw the Marijuana Industry into Chaos":
Jul 8, 2024
For instance, if a federal agency says a product can't contain a certain amount of CBD, companies can more easily challenge that decision in court. The agency can no longer rely solely on its supposed expertise to defend its rules.
https://cannabis.net/blog/news/how-the-supreme-court-overturning-a-case-against-chevron-oil-threw-the-marijuana-industry-into
👍️ 1 ☠️ 1
DarthYoda DarthYoda 7 meses hace
Yeah, there's always that question of when. Maybe the Chevron ruling will combine with rescheduling to make schedule 3 even more meaningful to companies. At the very least, companies soon won't have to remove every molecule of THC to gain FDA approval...
"Cannabis Medications Could Be Eligible For FDA Approval Under Proposed DEA Rules":
July 8, 2024
The US Drug Enforcement Administration has proposed new rules that mean, for the first time, medications containing delta-9 THC from the cannabis plant could be eligible for approval by the US Food and Drug Administration (FDA).
https://www.cannabisculture.com/content/2024/07/08/cannabis-medications-could-be-eligible-for-fda-approval-under-proposed-dea-rules/
👍️ 1 👎️ 1 ☠️ 1
Thomas@yahoo Thomas@yahoo 7 meses hace
https://www.barchart.com/stocks/quotes/CWBHF/opinion
👍️ 1
GE_Jim GE_Jim 7 meses hace
Thats a good info post. The question will be on how long.
👎️ 1
DarthYoda DarthYoda 7 meses hace
"Supreme Court’s Chevron Doctrine Ruling Could Limit FDA’s Regulatory Authority":
Jul 01, 2024
In overruling Chevron on Friday, the Supreme Court ushered in a new framework, dubbed Loper Bright. Courts are now required to “exercise their independent judgement in deciding whether an agency has acted within its statutory authority” and “may not defer to an agency interpretation of the law simply because a statute is ambiguous.”

This new framework could have significant consequences for the FDA and its regulatory authority, according to an analysis by global law firm Sidley.

The firm contends that Loper Bright could potentially open the regulator’s drug approvals to legal challenges. Companies need to provide “substantial evidence” that their drug candidates are safe and effective before securing approval, but courts in the past have found this ambiguous and have allowed the FDA to ask for additional requirements, such as data showing that the candidate’s effects are clinically meaningful, according to Sidley.

Under Loper Bright, more companies could try and challenge this approach, Sidley warned.

The overturning of Chevron could also pose some jurisdictional questions for the FDA, which is typically given the leeway to decide what constitutes a dietary supplement or a device product. These kinds of determinations affect how products are regulated, produced, or imported—and companies can now mount stronger challenges to this function by the FDA.
https://www.biospace.com/article/supreme-court-s-chevron-doctrine-ruling-could-limit-fda-s-regulatory-authority/
Here are two opposing opinions on how the chevron decision could affect rescheduling...
https://www.marijuanamoment.net/the-supreme-court-nuked-cannabis-rescheduling-with-its-chevron-ruling-op-ed/
https://www.marijuanamoment.net/reports-of-marijuana-reschedulings-chevron-related-death-are-greatly-exaggerated-op-ed/
👎️ 1 ☠️ 1
DarthYoda DarthYoda 7 meses hace
FYI-"The FDA’s power to determine a drug’s exclusivity or review tobacco marketing applications faces fresh vulnerability to legal battles after the Supreme Court’s decision to nix a legal doctrine that empowered agency interpretations.

The US Supreme Court’s June 28 opinion in Loper Bright Enters. v. Raimondo is expected to open the floodgates for litigation against the Food and Drug Administration after ending the decades-old Chevron doctrine. Under the 1984 decision in Chevron v. Natural Resources Defense Council, courts had accepted a federal agency’s reasonable interpretation of its rulemaking authority when its statute was determined ambiguous."
https://news.bloomberglaw.com/health-law-and-business/fda-drug-approvals-rulemaking-are-tested-after-chevron-decision
👍️ 1 ☠️ 1
Thomas@yahoo Thomas@yahoo 7 meses hace
https://hemptoday.net/struggles-continued-for-charlottes-web-in-first-quarter-as-losing-streak-continued/
👍️ 2 ☠️ 2
Thomas@yahoo Thomas@yahoo 7 meses hace
https://x.com/hemproundtable/status/1805986743042072861?s=61
🇵🇱 1 🇺🇲 1
Wolf-man jack Wolf-man jack 7 meses hace
This will open the door for +Plus CBD

https://finance.yahoo.com/news/charlottes-debuts-walmart-cbd-topical-121500999.html
🇵🇱 1 🇺🇲 2 👍️ 1
ap17 ap17 7 meses hace
.10 ea coming, wait a bit longer to get 3 for a quarter.
👍️0
N.C.LUCKY(7) N.C.LUCKY(7) 7 meses hace
It will hit 0.10 in July.. Great buying opportunity an the closer we get to November elections the cannabis sector will start heating up...
👍️0
Wolf-man jack Wolf-man jack 7 meses hace
Another Cash Burn 🔥 In The Anus YQU Understand. Who takes his place, Smokey Joe? Have Mercy WQLF Ahooooooo

http://archive.fast-edgar.com/20240614/AWZZV62CZ22BRZZ222242ZZZQU79ZZTS4262/

Wolfman Jack Says: CWBHF Shareholders get humped over again YQU Understand. Have Mercy Ahooooooo

👍️ 1 🔟 1 ☠️ 1 ⬇️ 1
Wolf-man jack Wolf-man jack 8 meses hace
In my opinion, It doesn’t appear that BAT is investing in OGI and CWBHF for any other reason, but to make sure their investments are protected. Most likely there would be no mergers planned for the two entities along with BAT. Poison pills 💊 in both agreements. But agreements can be negotiated for any and all reasons as long as both parties agree. The recent tranche of funds for the Jupiter program of acquiring other cannabis companies could prove me wrong. With the limited amount of funds available, they are considering smaller companies. Unless, they offer equity and stock for any possible acquisition of CWBHF by OGI.

“ BAT will subscribe for 12,893,175 million shares on the closing of the first tranche (currently expected to be on or around January 16, 2024) for gross proceeds of C$41.5 million with the remaining 25,786,350 shares to be subscribed for in two further equal tranches on or around August 30, 2024 and February 28, 2025.

To the extent BAT exceeds 30.0% holding of outstanding Common Shares, it will be issued non-voting Class A convertible preferred shares ("Preferred Shares"). Accordingly, in aggregate, based on Organigram’s current 81,161,630 Common Shares outstanding, 12,999,231 Common Shares will be issued, and the remaining 25,680,294 shares will be initially issued as Preferred Shares. The Preferred Shares will be eligible for conversion into voting Common Shares at BAT’s option, provided that such conversion would not result in BAT’s voting interest in the Company exceeding 30%.

In connection with the closing of the first tranche of the Investment and subject to approval by Organigram’s shareholders, the Company will file articles of amendment to create the new class of Preferred Shares to be issued to BAT in the Investment.

Class A Preferred Shares

Each Preferred Share shall be economically equivalent to a Common Share and will be convertible into Common Shares at the option of BAT without payment of any additional consideration. The conversion ratio shall initially be one-for-one, and post-issuance shall increase at a rate of 7.5% per annum, compounded annually, until such time as the Preferred Shares are converted into Common Shares or the aggregate equity interest of BAT in Organigram (inclusive of both the Common Shares and Preferred Shares as if converted into Common Shares) reaches 49%. BAT shall be periodically required to convert Preferred Shares to the extent that it holds less than 30% of the Common Shares outstanding”
🇨🇦 1 🇺🇲 1 👍️ 1 ☠️ 1

Su Consulta Reciente

Delayed Upgrade Clock